The company manufactures soft ferrite cores and pre-calcined ferrite powder used in power electronics for applications like electric vehicle chargers, solar inverters, and automotive sensors.
The company operates in a commodity-like industry with low barriers to entry, evidenced by negative average net margins and poor returns on capital. While management claims a moat through R&D and niche products, the financial reality shows a business struggling to compete with low-cost imports and unable to generate consistent profits.
Capital has been deployed into capacity expansions and R&D that have failed to yield positive returns, resulting in chronic losses and a high debt-to-equity ratio of 3.0. The company has been forced to halt dividends and redeem preference shares while interest coverage remains dangerously low.
The company's insolvency became inevitable as the massive debt load, currently at a 3.0 debt-to-equity ratio, finally crushed the balance sheet when interest coverage remained below 1.0. Despite management's promises of R&D-led growth, the business remained a commodity price-taker unable to pass on costs, leading to a liquidity crunch that forced a fire sale or restructuring. The reliance on government protection through anti-dumping duties proved a fragile crutch that eventually failed to offset the structural lack of profitability and poor capital allocation.
RichFakir rates Cosmo Ferrites Ltd's business quality as poor — 0/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Cosmo Ferrites Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Cosmo Ferrites Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Cosmo Ferrites Ltd's fair value is about ₹4 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →